Sign In
Buy BHC
$4.95
-0.0600 (-1.20%)
At Close: Jun 03, 2026
Bausch Health Companies Inc. (BHC) Management Presents at Goldman Sachs Fifth Annual Leveraged Finance Conference (Transcript)
05:20pm, Thursday, 25'th Jun 2020
Bausch Health Companies Inc. (NYSE:BHC) Goldman Sachs Fifth Annual Leveraged Finance Conference June 25, 2020, 11:25 AM ET Company Participants Paul Herendeen -
Ortho Dermatologics Launches ARAZLO™ (tazarotene) Lotion, 0.045%, In The United States
11:00am, Tuesday, 23'rd Jun 2020
LAVAL, QC , June 23, 2020 /CNW/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) and its dermatology business, Ortho Dermatologics, one of the largest prescription dermatology health care businesses
The Buy Case For Bausch Health
12:53pm, Monday, 22'nd Jun 2020
Bausch Health Companies Inc. has rebounded ~60% from its mid-March intraday lows but still remains ~40% below its mid-January 2020 highs. Extremely high leverag
BAUSCH + LOMB ULTRA® Silicone Hydrogel Contact Lenses Receive Approval In China
08:15pm, Wednesday, 17'th Jun 2020
Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health"), today announced that BAUSCH + LOMB ULTRA® monthly silicone hydrogel contact lens
Bausch Health to Participate at Goldman Sachs Annual Leveraged Finance Conference
11:00am, Tuesday, 16'th Jun 2020
Bausch Health Companies Inc. (NYSE/TSX: BHC) today announced that Paul S. Herendeen, executive vice president and chief financial officer, Arthur J. Shannon, senior vice president and head of Investor
Salix Announces Inaugural Salix Gastrointestinal Health Scholars Program Recipients
11:00am, Monday, 15'th Jun 2020
Bausch Health Companies Inc. (NYSE/TSX: BHC) and its gastroenterology business, Salix Pharmaceuticals ("Salix"), one of the largest specialty pharmaceutical companies in the world committed to the pre
Health Canada Issues Notice of Compliance for Bausch Health's DUOBRII™
11:00am, Thursday, 11'th Jun 2020
Health Canada Issues Notice of Compliance for Bausch Health's DUOBRII™
Bausch (BHC) Up 21.2% Since Last Earnings Report: Can It Continue?
03:31pm, Saturday, 06'th Jun 2020
Bausch (BHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
FDA Provides 510(k) Clearance For BAUSCH + LOMB INFUSE™ Daily Disposable Silicone Hydrogel (SiHy Daily) Contact Lenses
11:00am, Thursday, 04'th Jun 2020
Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health"), today announced that it has received 510(k) clearance from the U.S. Food and Drug
Hedge Funds Are Getting Crazy About Bausch Health Companies (BHC)
07:23am, Wednesday, 03'rd Jun 2020
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first. This is a necessary first step in our investmen
Edited Transcript of BHC earnings conference call or presentation 7-May-20 12:00pm GMT
04:43am, Wednesday, 03'rd Jun 2020
Q1 2020 Bausch Health Companies Inc Earnings Call
2 Healthcare Stocks At High Risk Of A Writedown
12:00pm, Sunday, 31'st May 2020
Investing in companies that are forced to write down their assets due to botched acquisitions can have devastating consequences for investors.
Bausch + Lomb Announces The European Launch Of LuxSmart™ And LuxGood™ Preloaded Intraocular Lenses
11:00am, Wednesday, 27'th May 2020
Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health"), today announced the European launch of the company's first Extended Depth of Focu
Anterix and Bausch Holding See Activist Action
11:00pm, Friday, 22'nd May 2020
Owl Creek Asset Management increased its stake in wireless-communications firm Anterix, while Paulson & Co. bought more Bausch stock.
Francis Chou Slims 4 Positions in the 1st Quarter
10:46pm, Friday, 22'nd May 2020
Canadian guru releases portfolio. Sells include major Berkshire bank holding Bank of America. Continue reading...
